Sentinel lymph node detection using 99mTc combined with methylene blue cervical injection for endometrial cancer surgical management

A prospective study

Carlos López De La Manzanara Cano, José M.Cordero García, Cástor Martín-Francisco, Francisco Pascual-Ramirez, Celia Pérez Parra, Carmen Céspedes Casas

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Objective: The aim of this study is to evaluate the effectiveness of a combined technique for sentinel lymph node (SLN) localization and surgical staging of endometrial carcinoma. Methods: This is a single-center prospective observational study carried out from September 2011 to December 2013 including women with a diagnosis of endometrial cancer and scheduled for surgery. A regional lymph node mapping was obtained using SPECT-CT (cervical injection of 99mTc) the day before surgery. On the day of surgery, methylene blue was injected in the cervical tissue. The SLNs were identified intraoperatively guided both by a F-probe and visual inspection of the blue dye. A pelvic and/or para-aortic lymphadenectomy was completed. A histological analysis was performed on all the removed lymph nodes. We calculated the detection rate for SLN and its negative predictive value (NPV) for malignancy. Results: Fifty patients underwent surgery. The SLN was isolated in 46 patients with detection rate of 92% (95% confidence interval, 80.77Y97.78). The mean number of detected SLNs per patient was 1.54 (range, 1Y5); the average number of non-SLNs removed was 17 (5Y34) per patient. The most common SLN location was the external iliac lymph node chain, 33 (46.47%). Five SLNs (7.1%) were isolated in the para-aortic chain. Three SLN cases (5.9%) were positive for malignant cells; the totality of the remaining non-SLNs was negative. The NPVof the SLN was 100% (95% confidence interval, 89.79Y99.79). Finally, pathologic findings were 42 endometrioid types (84%), 3 carcinosarcomas (6%), 4 clear cell (8%), and 1 serous papillary tumor (2%). Conclusions: The SLN analysis may be useful to assess the presence or absence of lymph node metastases. Its high NPV may be used as criteria to avoid unnecessary lymphadenectomies in endometrial cancer patients.

Original languageEnglish (US)
Pages (from-to)1048-1053
Number of pages6
JournalInternational Journal of Gynecological Cancer
Volume24
Issue number6
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Methylene Blue
Endometrial Neoplasms
Prospective Studies
Injections
Lymph Nodes
Lymph Node Excision
Ambulatory Surgical Procedures
Confidence Intervals
Carcinosarcoma
Sentinel Lymph Node
Observational Studies
Neoplasms
Coloring Agents
Neoplasm Metastasis

Keywords

  • Endometrial cancer
  • Sentinel lymph node
  • Sentinel lymph node mapping
  • SPECT/CT
  • Technetium

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Cite this

Sentinel lymph node detection using 99mTc combined with methylene blue cervical injection for endometrial cancer surgical management : A prospective study. / Cano, Carlos López De La Manzanara; García, José M.Cordero; Martín-Francisco, Cástor; Pascual-Ramirez, Francisco; Parra, Celia Pérez; Casas, Carmen Céspedes.

In: International Journal of Gynecological Cancer, Vol. 24, No. 6, 01.01.2014, p. 1048-1053.

Research output: Contribution to journalArticle

Cano, Carlos López De La Manzanara ; García, José M.Cordero ; Martín-Francisco, Cástor ; Pascual-Ramirez, Francisco ; Parra, Celia Pérez ; Casas, Carmen Céspedes. / Sentinel lymph node detection using 99mTc combined with methylene blue cervical injection for endometrial cancer surgical management : A prospective study. In: International Journal of Gynecological Cancer. 2014 ; Vol. 24, No. 6. pp. 1048-1053.
@article{cda2672c6c194264be57a800f763c9b3,
title = "Sentinel lymph node detection using 99mTc combined with methylene blue cervical injection for endometrial cancer surgical management: A prospective study",
abstract = "Objective: The aim of this study is to evaluate the effectiveness of a combined technique for sentinel lymph node (SLN) localization and surgical staging of endometrial carcinoma. Methods: This is a single-center prospective observational study carried out from September 2011 to December 2013 including women with a diagnosis of endometrial cancer and scheduled for surgery. A regional lymph node mapping was obtained using SPECT-CT (cervical injection of 99mTc) the day before surgery. On the day of surgery, methylene blue was injected in the cervical tissue. The SLNs were identified intraoperatively guided both by a F-probe and visual inspection of the blue dye. A pelvic and/or para-aortic lymphadenectomy was completed. A histological analysis was performed on all the removed lymph nodes. We calculated the detection rate for SLN and its negative predictive value (NPV) for malignancy. Results: Fifty patients underwent surgery. The SLN was isolated in 46 patients with detection rate of 92{\%} (95{\%} confidence interval, 80.77Y97.78). The mean number of detected SLNs per patient was 1.54 (range, 1Y5); the average number of non-SLNs removed was 17 (5Y34) per patient. The most common SLN location was the external iliac lymph node chain, 33 (46.47{\%}). Five SLNs (7.1{\%}) were isolated in the para-aortic chain. Three SLN cases (5.9{\%}) were positive for malignant cells; the totality of the remaining non-SLNs was negative. The NPVof the SLN was 100{\%} (95{\%} confidence interval, 89.79Y99.79). Finally, pathologic findings were 42 endometrioid types (84{\%}), 3 carcinosarcomas (6{\%}), 4 clear cell (8{\%}), and 1 serous papillary tumor (2{\%}). Conclusions: The SLN analysis may be useful to assess the presence or absence of lymph node metastases. Its high NPV may be used as criteria to avoid unnecessary lymphadenectomies in endometrial cancer patients.",
keywords = "Endometrial cancer, Sentinel lymph node, Sentinel lymph node mapping, SPECT/CT, Technetium",
author = "Cano, {Carlos L{\'o}pez De La Manzanara} and Garc{\'i}a, {Jos{\'e} M.Cordero} and C{\'a}stor Mart{\'i}n-Francisco and Francisco Pascual-Ramirez and Parra, {Celia P{\'e}rez} and Casas, {Carmen C{\'e}spedes}",
year = "2014",
month = "1",
day = "1",
doi = "10.1097/IGC.0000000000000158",
language = "English (US)",
volume = "24",
pages = "1048--1053",
journal = "International Journal of Gynecological Cancer",
issn = "1048-891X",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Sentinel lymph node detection using 99mTc combined with methylene blue cervical injection for endometrial cancer surgical management

T2 - A prospective study

AU - Cano, Carlos López De La Manzanara

AU - García, José M.Cordero

AU - Martín-Francisco, Cástor

AU - Pascual-Ramirez, Francisco

AU - Parra, Celia Pérez

AU - Casas, Carmen Céspedes

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Objective: The aim of this study is to evaluate the effectiveness of a combined technique for sentinel lymph node (SLN) localization and surgical staging of endometrial carcinoma. Methods: This is a single-center prospective observational study carried out from September 2011 to December 2013 including women with a diagnosis of endometrial cancer and scheduled for surgery. A regional lymph node mapping was obtained using SPECT-CT (cervical injection of 99mTc) the day before surgery. On the day of surgery, methylene blue was injected in the cervical tissue. The SLNs were identified intraoperatively guided both by a F-probe and visual inspection of the blue dye. A pelvic and/or para-aortic lymphadenectomy was completed. A histological analysis was performed on all the removed lymph nodes. We calculated the detection rate for SLN and its negative predictive value (NPV) for malignancy. Results: Fifty patients underwent surgery. The SLN was isolated in 46 patients with detection rate of 92% (95% confidence interval, 80.77Y97.78). The mean number of detected SLNs per patient was 1.54 (range, 1Y5); the average number of non-SLNs removed was 17 (5Y34) per patient. The most common SLN location was the external iliac lymph node chain, 33 (46.47%). Five SLNs (7.1%) were isolated in the para-aortic chain. Three SLN cases (5.9%) were positive for malignant cells; the totality of the remaining non-SLNs was negative. The NPVof the SLN was 100% (95% confidence interval, 89.79Y99.79). Finally, pathologic findings were 42 endometrioid types (84%), 3 carcinosarcomas (6%), 4 clear cell (8%), and 1 serous papillary tumor (2%). Conclusions: The SLN analysis may be useful to assess the presence or absence of lymph node metastases. Its high NPV may be used as criteria to avoid unnecessary lymphadenectomies in endometrial cancer patients.

AB - Objective: The aim of this study is to evaluate the effectiveness of a combined technique for sentinel lymph node (SLN) localization and surgical staging of endometrial carcinoma. Methods: This is a single-center prospective observational study carried out from September 2011 to December 2013 including women with a diagnosis of endometrial cancer and scheduled for surgery. A regional lymph node mapping was obtained using SPECT-CT (cervical injection of 99mTc) the day before surgery. On the day of surgery, methylene blue was injected in the cervical tissue. The SLNs were identified intraoperatively guided both by a F-probe and visual inspection of the blue dye. A pelvic and/or para-aortic lymphadenectomy was completed. A histological analysis was performed on all the removed lymph nodes. We calculated the detection rate for SLN and its negative predictive value (NPV) for malignancy. Results: Fifty patients underwent surgery. The SLN was isolated in 46 patients with detection rate of 92% (95% confidence interval, 80.77Y97.78). The mean number of detected SLNs per patient was 1.54 (range, 1Y5); the average number of non-SLNs removed was 17 (5Y34) per patient. The most common SLN location was the external iliac lymph node chain, 33 (46.47%). Five SLNs (7.1%) were isolated in the para-aortic chain. Three SLN cases (5.9%) were positive for malignant cells; the totality of the remaining non-SLNs was negative. The NPVof the SLN was 100% (95% confidence interval, 89.79Y99.79). Finally, pathologic findings were 42 endometrioid types (84%), 3 carcinosarcomas (6%), 4 clear cell (8%), and 1 serous papillary tumor (2%). Conclusions: The SLN analysis may be useful to assess the presence or absence of lymph node metastases. Its high NPV may be used as criteria to avoid unnecessary lymphadenectomies in endometrial cancer patients.

KW - Endometrial cancer

KW - Sentinel lymph node

KW - Sentinel lymph node mapping

KW - SPECT/CT

KW - Technetium

UR - http://www.scopus.com/inward/record.url?scp=84904169723&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904169723&partnerID=8YFLogxK

U2 - 10.1097/IGC.0000000000000158

DO - 10.1097/IGC.0000000000000158

M3 - Article

VL - 24

SP - 1048

EP - 1053

JO - International Journal of Gynecological Cancer

JF - International Journal of Gynecological Cancer

SN - 1048-891X

IS - 6

ER -